Selective inhibitors for JNK signalling: a potential targeted therapy in cancer
Q Wu, W Wu, V Jacevic, TCC Franca… - Journal of enzyme …, 2020 - Taylor & Francis
Abstract c-Jun N-terminal kinase (JNK) signalling regulates both cancer cell apoptosis and
survival. Emerging evidence show that JNK promoted tumour progression is involved in …
survival. Emerging evidence show that JNK promoted tumour progression is involved in …
A cross-talk about radioresistance in lung cancer—How to improve radiosensitivity according to Chinese medicine and medicaments that commonly occur in …
P Nowak, I Bil-Lula, M Śliwińska-Mossoń - International Journal of …, 2023 - mdpi.com
Lung cancer is one of the most common cancers in the population and is characterized by
non-specific symptoms that delay the diagnosis and reduce the effectiveness of oncological …
non-specific symptoms that delay the diagnosis and reduce the effectiveness of oncological …
JNK, p38, ERK, and SGK1 inhibitors in cancer
J Cicenas, E Zalyte, A Rimkus, D Dapkus, R Noreika… - Cancers, 2017 - mdpi.com
Mitogen-activated protein kinases (MAP kinases) are a family of kinases that regulates a
range of biological processes implicated in the response to growth factors like latelet …
range of biological processes implicated in the response to growth factors like latelet …
Rosiglitasone and ROCK inhibitors modulate fibrogenetic changes in TGF-β2 treated human conjunctival fibroblasts (HconF) in different manners
Y Oouchi, M Watanabe, Y Ida, H Ohguro… - International Journal of …, 2021 - mdpi.com
Purpose: The effects of Rho-associated coiled-coil containing protein kinase (ROCK) 1 and
2 inhibitor, ripasudil hydrochloride hydrate (Rip), ROCK2 inhibitor, KD025 or rosiglitazone …
2 inhibitor, ripasudil hydrochloride hydrate (Rip), ROCK2 inhibitor, KD025 or rosiglitazone …
JNK signaling as a target for anticancer therapy
The JNKs are members of mitogen-activated protein kinases (MAPK) which regulate many
physiological processes including inflammatory responses, macrophages, cell proliferation …
physiological processes including inflammatory responses, macrophages, cell proliferation …
Advances in immunosuppressive agents based on signal pathway
Z Xu, M Chu - Frontiers in Pharmacology, 2022 - frontiersin.org
Immune abnormality involves in various diseases, such as infection, allergic diseases,
autoimmune diseases, as well as transplantation. Several signal pathways have been …
autoimmune diseases, as well as transplantation. Several signal pathways have been …
Microarray analysis of metallothioneins in human diseases—A review
S Krizkova, M Kepinska, G Emri, MAM Rodrigo… - … of pharmaceutical and …, 2016 - Elsevier
Metallothioneins (MTs), low molecular mass cysteine-rich proteins, which are able to bind up
to 20 monovalent and up to 7 divalent heavy metal ions are widely studied due to their …
to 20 monovalent and up to 7 divalent heavy metal ions are widely studied due to their …
Muscarinic receptor agonist-induced βPix binding to β-catenin promotes colon neoplasia
K Cheng, A Chahdi, SM Larabee, M Tolaymat… - Scientific reports, 2023 - nature.com
Abstract M3 muscarinic receptors (M3R) modulate β-catenin signaling and colon neoplasia.
CDC42/RAC guanine nucleotide exchange factor, βPix, binds to β-catenin in colon cancer …
CDC42/RAC guanine nucleotide exchange factor, βPix, binds to β-catenin in colon cancer …
[HTML][HTML] Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway
K Wu, Y Yang, D Liu, Y Qi, C Zhang, J Zhao, S Zhao - Oncotarget, 2016 - ncbi.nlm.nih.gov
Although substantial studies on peroxisome proliferator-activated receptor γ (PPARγ) have
focused on the mechanisms by which PPARγ regulates glucose and lipid metabolism …
focused on the mechanisms by which PPARγ regulates glucose and lipid metabolism …
Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
Y Xu, R Liu - Heliyon, 2022 - cell.com
Objective To study the role of m6A and lncRNAs in the prognosis and immunotherapy of
hepatocellular carcinoma, construct the risk score of overall survival of hepatocellular …
hepatocellular carcinoma, construct the risk score of overall survival of hepatocellular …